France’s next PrEP study aims to assess the wider impact of PrEP on the HIV epidemic
Dutch study finds out whether gay men prefer daily or on-demand PrEP
Long-acting cabotegravir injection shows promise for HIV prevention
Doravirine combination pill looks good for initial HIV treatment
Acute kidney injury ‘uncommon’ but unpredictable on tenofovir and ritonavir
Countries and donors should aim for new $90-$90-$90 target on HIV, hepatitis, TB drug prices, study shows
Medical male circumcision for HIV has benefits for women too
Demonstration projects explore the feasibility of PrEP for adolescents and young women in South Africa
Ipergay trial: PrEP still protected people who had less sex and used it less often
Another HIV vaccine efficacy trial will start this year
Glecaprevir/pibrentasvir is effective for people with HIV/HCV co-infection
90-90-90 progress in southern Africa: HIV testing gap needs to be closed in young people and men
Can self-testing engage 'hard-to-reach' men with HIV testing?
Integrase inhibitors not causing higher rates of adverse birth outcomes, Botswana and French studies show
New guidance says start HIV treatment within 7 days of diagnosis – but is everyone ready?
International study of gay couples reports no transmissions from an HIV-positive partner on treatment
New integrase inhibitor bictegravir works well for first-line HIV treatment
Hepatitis C treatment is effective and feasible in Africa
